Credit Suisse’s Passage Bio PASG Stock Holding History

Credit Suisse’s Portfolio PASG Stock Details PASG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1	Closed	–	–	4213
2022 Q2	$0	Sell	1 -911	-100%	-$42.6K	﹤0.01%	4203
2022 Q1	$56K	Sell	912 -54	-6%	-$4.45K	﹤0.01%	3511
2021 Q4	$123K	Buy	966 +261	+37%	+$42.6K	﹤0.01%	4362
2021 Q3	$140K	Buy	705 +15	+2%	+$3.58K	﹤0.01%	4289
2021 Q2	$182K	Sell	690 -20	-3%	-$6.19K	﹤0.01%	4299
2021 Q1	$249K	Sell	710 -95	-12%	-$40.6K	﹤0.01%	4059
2020 Q4	$412K	Buy	+805	New	+$322K	﹤0.01%	3883

Other funds holding PASG

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HCM

Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Credit Suisse's PASG Position: Q3 2022 in Review

Credit Suisse sold out of Passage Bio (PASG) in Q3 2022, closing a stake of 1 share.

Credit Suisse first reported a position in PASG in Q4 2020 and held it in 7 quarters. The position peaked at $412K in Q4 2020. 75 funds tracked by Wall St. Rank hold PASG as of Q3 2022.

Credit Suisse reported no remaining Passage Bio position as of Q3 2022 after selling out during the quarter.
Credit Suisse sold 1 Passage Bio share in Q3 2022.
Credit Suisse first reported a position in Passage Bio in Q4 2020 and held it in 7 quarters.
Credit Suisse's Passage Bio position peaked at $412K in Q4 2020.
75 funds tracked by Wall St. Rank held Passage Bio as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.